|
|||||||
![]() |
![]() |
||||||
|
IntroductionCompany ProfileSciClone Pharmaceuticals is a profit-driven, global specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. Internationally SciClone has built a strong commercial organization, delivering consistent, double-digit revenue growth through an expanding product portfolio. Our sales in countries like China and Russia help support SciClone's international development programs. Many of our products on the market and in development have the potential to treat multiple indications and work safely in concert with other drugs to help improve overall care.
Business Strategy In addition to improving patients' lives around the world, SciClone is committed to generating value for its investors by growing worldwide revenues, achieving sustainable profitability and maintaining a solid financial position. We plan to drive this value-focused objective by rapidly expanding our presence in key geographies by –in-licensing new products to market. Leveraging the strong organizational structure and commercial expertise we have built in China, we have strategically positioned SciClone as an ideal partner for introducing promising therapies to that region.
|
|||||||
| © 2010 SciClone Pharmaceuticals, Inc. All rights reserved. Please read our disclaimer. Terms of Use | Notes Regarding Forward-Looking Statements |
|||||||